6.200
−1,59%
2026-10-19
Fundamental Analysis
57 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +49.8% | +258.2% | 2 / 3 | +0.6% | +1.12 pp | +0.63 pp | +7.7% | 1.33 | 6.80 | 188 | +0,6% | 3,6 | +49,8% | 6.80 | 10.02 | −32,2% |
| Pts | 8 | 12 | 8 | 0 | 8 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 6.200 (close price on 2026-10-19)EPS (TTM): 912,0
Financial charts
1.Revenue & growth
VND bn188Q2/26
1.Revenue & growth
VND bn188Q2/26
2.Profit & growth
VND bn3,59Q2/26
3.Profit mix (Penman)
VND bn24,9Q2/26
4.Margins & cost structure
%23.6%Q2/26
5.Returns & cash cycle
% · days7.0%Q2/26
6.Earnings quality & cash
VND bn39,9Q2/26
7.Asset structure
VND bn710Q2/26
8.Funding & debt health
VND bn · times710Q2/26
9.Revenue backlog
VND bn0,07Q2/26
10.Valuation
times · %6,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %150Q2/26
Adjusted EPS growth, latest quarter
49.8%
Average adjusted EPS growth, 3 quarters
258%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26